QARS1
protein-codingglutaminyl-tRNA synthetase 1, the group of MicroRNA protein coding host genes|Aminoacyl tRNA synthetases, Class I
Gene summary
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. In metazoans, 9 aminoacyl-tRNA synthetases specific for glutamine (gln), glutamic acid (glu), and 7 other amino acids are associated within a multienzyme complex. Although present in eukaryotes, glutaminyl-tRNA synthetase (QARS) is absent from many prokaryotes, mitochondria, and chloroplasts, in which Gln-tRNA(Gln) is formed by transamidation of the misacylated Glu-tRNA(Gln). Glutaminyl-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
- QARS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014335
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014335
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018494
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014335
Submitter: ClinGen
QARS was reported in relation to diffuse cerebral and cerebellar atrophy-intractable seizures – progressive microcephaly syndrome in 2014 (PMID: 24656866). Evidence supporting this gene-disease relationship is case-level data and functional characterization. Variants in this gene have been reported in at least 8 individuals, including 2 sets of affected siblings (PMID: 27717089, 31618474, 25471517, 25432320, 24656866). This is insufficient to reach the maximum amount of case level data. However, several additional pathogenic LoF variants are reported in ClinVar. Variants in this gene are known to disrupt the protein interactions with other disease genes, RARS (PMID: 24656866). Additionally a knock-out zebrafish model was generated with recapitulated the human phenotype (PMID: 24656866). The mechanism for disease is loss of function. In summary, QARS is definitively associated with diffuse cerebral and cerebellar atrophy-intractable seizures – progressive microcephaly syndrome.
Inheritance Pattern: AR
Disease ID:MONDO:0014335
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to QARS1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005051.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 218 | 3 | 228 | ||
| missense | 15 | 408 | 15 | 1 | 439 | |
| nonsense | 13 | 6 | 2 | 21 | ||
| start loss | 2 | 2 | ||||
| frameshift | 25 | 6 | 2 | 33 | ||
| splice donor/acceptor (+/-2bp) | 20 | 12 | 32 | |||
| Total | 40 | 47 | 431 | 233 | 4 | 755 |
Highest pathogenic variant AF is 0.00008054483
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005042.1 | 24 | MANE Select | |
| Ensembl | ENSP00000307567.6 | 24 | MANE Select | |
| RefSeq | NP_001259002.1 | 24 | Standard | |
| Ensembl | ENSP00000390015.1 | 24 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| qars | Danio rerio | Structure: head Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- 2-Hydroxyglutric Aciduria (D And L Form)
- Homocarnosinosis
- Hyperinsulinism-Hyperammonemia Syndrome
- Succinic semialdehyde dehydrogenase deficiency
Biological Process
- tRNA aminoacylation for protein translation
- glutaminyl-tRNA aminoacylation
- negative regulation of protein kinase activity
- brain development
- negative regulation of stress-activated MAPK cascade
Molecular Function
- glutamine-tRNA ligase activity
- protein kinase inhibitor activity
- protein binding
- ATP binding
- protein kinase binding
Cellular Component
- cytoplasm
- mitochondrial matrix
- cytosol
- aminoacyl-tRNA synthetase multienzyme complex
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000306125
- Coding exons
- 24
- Length
- 9189
- Individuals with no LoFs
- 125656
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 92
- Defined
- 125748
- p
- 0.000366
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.220 | 438 | 451 | 0.971 | 0.0000267 | 5022 |
| Missense (PolyPhen) | 203 | 232.08 | 0.87469 | 2638 | ||
| Synonymous | -1.03 | 184 | 167 | 1.10 | 0.00000884 | 1529 |
| Loss of Function | 2.64 | 28 | 47.6 | 0.588 | 0.00000257 | 533 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00058 | 0.00058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00045 | 0.00045 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Glutamine--tRNA ligase (PubMed:26869582). Plays a critical role in brain development (PubMed:24656866). {ECO:0000269|PubMed:24656866, ECO:0000269|PubMed:26869582}.;
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- LoFtool
- 0.889
- RVIS EVS
- -0.64
- RVIS percentile EVS
- 16.68
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.992
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |